Description
BLOOD PRODUCTS
First action · last action
2021-10-01 · 2023-07-12
Transactions
2
First transaction's obligation
$540,450
Base + all options value (sum of deltas)
$431,219
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
339113 · SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-01+$540,450= $540,450
- Mod P000012023-07-12-$109,231= $431,219
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-01 | +$540,450 | $540,450 | BLOOD PRODUCTS |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2023-07-12 | −$109,231 | $431,219 | BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Z9HUQ54LMDR4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926A0003 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24926N0200 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $594,875 | FY2026 |
| 36C24925P0025 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $399,994 | FY2025 |
| 36C24924P0025 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $377,262 | FY2024 |
| 36C24923P0025 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $439,409 | FY2023 |
| 36C24921P0033 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $404,782 | FY2021 |
Other recipients under 6550 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926N0666 | BIOMERIEUX INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $982,841 | FY2026 |
| 36C24926N0645 | BIOMERIEUX INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $140,256 | FY2026 |
| 36C24926N0573 | BIOMERIEUX INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $191,530 | FY2026 |
| 36C24926N0572 | BIOMERIEUX INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $33,607 | FY2026 |
| 36C24926N0567 | BIOMERIEUX INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $750,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24922P0013_3600_-NONE-_-NONE- · retrieved 2026-09-27.